Prevalent and Incident Drug Use in a Pediatric Population: A Descriptive Analysis

    Basic Details
    Date Posted
    Monday, January 11, 2021
    Status
    Complete
    Medical Product
    acetaminophen with codeine
    acyclovir
    acyclovir sodium
    albuterol
    albuterol sulfate
    levalbuterol HCL
    levalbuterol tartrate
    nitazoxanide
    nizatidine
    oxycodone HCL
    sucralfate
    Description

    In this request we examined prevalent and incident use of acetaminophen with codeine, acyclovir/acyclovir sodium, nizatidine, albuterol/albuterol sulfate, levalbuterol HCl/levalbuterol tartrate, oxycodone HCl, nitazoxanide, and sucralfate among children aged 0 to 2 years. This request includes two reports:

    • Report 1: We included¬†the results where only drug coverage was required.
    • Report 2:¬†We included the results where both medical and drug coverage were required.

    The study period included data from January 1, 2000 to December 31, 2012. We distributed this request to 18 Data Partners on September 10, 2013.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2000 - December 31, 2012
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    Individuals 0 to 2 years of age
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)